Related Experiment Video
Updated: Jun 13, 2026
06:11
Monitoring Blood Glucose in Mouse Offspring After Intracytoplasmic Sperm Injection
Published on: May 17, 2024
Gestational diabetes screening after HAPO: has anything changed?
Wadia R Mulla1, Tasmia Q Henry, Carol J Homko
1Department of OB/GYN, Temple University School of Medicine, Philadelphia, PA 19140, USA. Wmulla@temple.edu
Current Diabetes Reports
|April 29, 2010
Summary
Gestational diabetes mellitus (GDM) affects many pregnancies. Current screening guidelines lack consensus, impacting maternal care despite evidence linking hyperglycemia to adverse pregnancy outcomes.
Area of Science:
- Obstetrics and Gynecology
- Endocrinology
- Public Health
Background:
- Gestational diabetes mellitus (GDM) is a common pregnancy complication, defined as diabetes first recognized during pregnancy.
- GDM diagnosis is crucial for maternal health care during and after pregnancy.
- Existing screening recommendations from major health organizations lack consensus.
Purpose of the Study:
- To summarize the current landscape of screening and diagnostic practices for gestational diabetes.
- To highlight the ongoing debate and lack of consensus in GDM screening guidelines.
- To underscore the importance of GDM diagnosis in managing pregnancy outcomes.
Main Methods:
- Review of current recommendations from key organizations (ADA, ACOG, WHO, National Diabetes Data Group).
- Analysis of findings from the Hyperglycemia and Adverse Pregnancy Outcome (HAPO) Study Group.
- Synthesis of recent research on the impact of hyperglycemia on pregnancy outcomes.
Main Results:
- Multiple organizations offer GDM screening recommendations, but no universal consensus exists.
- The HAPO study demonstrated a significant link between maternal hyperglycemia and adverse pregnancy outcomes.
- Emerging evidence suggests treating even mild hyperglycemia may reduce adverse outcomes.
Conclusions:
- There is a lack of consensus on optimal gestational diabetes screening and diagnostic criteria.
- Further research and guideline development are needed to address the impact of hyperglycemia on pregnancy.
- Standardized screening and diagnosis are essential for effective maternal and infant care.
More Related Videos
Related Concept Videos
01:22Diabetes Mellitus: Type 2 and Gestational
Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...
01:20Pathophysiology of Diabetes
Diabetes mellitus is a chronic metabolic disorder characterized by hyperglycemia. The four categories of diabetes are type 1 diabetes, type 2 diabetes, other specific types of diabetes, and gestational diabetes.
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility, suggesting a...
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility, suggesting a...
01:25Type II Diabetes Mellitus III: Clinical Manifestations and Diagnosis
Type 2 diabetes mellitus develops gradually and is often asymptomatic in early stages.Clinical ManifestationsWhen symptoms appear, they include fatigue, blurred vision, pruritus, delayed wound healing, and recurrent infections, particularly candidal infections. Peripheral neuropathy may present as numbness or tingling in the extremities. Classic hyperglycemia symptoms—polyuria, polydipsia, and polyphagia—are less common. Most patients are overweight and frequently have associated hypertension...
01:29Hyperglycemia
Hyperglycemia is an abnormally high blood glucose level. It is diagnosed by fasting glucose ≥126 mg/dL, 2-hour oral glucose tolerance test (or OGTT) ≥200 mg/dL, random glucose ≥200 mg/dL with symptoms, or HbA1c ≥6.5%. However, HbA1c results may be unreliable in certain conditions, such as anemia or hemoglobinopathies, and the diagnosis should be confirmed unless classic symptoms are present. Postprandial hyperglycemia is typically considered significant when glucose levels exceed 180 mg/dL two...
01:15Diabetes: Symptoms, Diagnosis, and Complications
For most patients, experiencing several weeks of polyuria, polydipsia, fatigue, and significant weight loss may indicate the presence of diabetes. Furthermore, adults displaying the phenotypic appearance of type 2 diabetes (particularly those who are obese and not initially insulin-requiring), may have islet cell autoantibodies, suggesting autoimmune-mediated β cell destruction and a diagnosis of latent autoimmune diabetes of adults (LADA). The categorization of glucose homeostasis is based on...
01:26Hypoglycemia
Hypoglycemia is a blood glucose level below 70 mg/dL. It commonly occurs in individuals using insulin or insulin-secreting drugs, but may also arise in non-diabetic conditions. People with type 1 diabetes are at the highest risk because they depend on exogenous insulin. People with type 2 diabetes are also at risk, especially when treated with insulin or medications such as sulfonylureas, which increase insulin release regardless of blood glucose levels. It develops when insulin levels exceed...